Bayer Launches Centafore Imaging Core Lab to Help Imaging for Scientific Trials and Software program as a Medical Gadget Growth

• Imaging Contract Analysis Group (iCRO) from Bayer providing tailor-made providers that can span all the imaging examine cycle from idea to completion
• Supporting early analysis via Section IV trials and Software program as a Medical Gadget (SaMD) growth for pharmaceutical, biotech, medical system, and digital well being corporations
• 25+ years of experience because the Imaging Core Lab for Bayer, supporting greater than 200 medical trials globally
• Bayer will probably be showcasing Centafore, its providers and know-how at this 12 months’s Annual Assembly of the American Society of Scientific Oncology (ASCO) in Chicago from Might 30 until June 3

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer immediately introduced the launch of its Imaging Core Lab Providers underneath the model identify Centafore. With over 25 years of expertise supporting greater than 200 medical trials at Bayer and its arm’s size corporations globally, Centafore is now positioned as a definite Imaging answer supplier, providing tailor-made providers for exterior clients to assist their medical trials and Software program as a Medical Gadget (SaMD) growth throughout numerous therapeutic areas and growth phases. Attendees of the 2025 Annual Assembly of the American Society of Scientific Oncology (ASCO) will get the possibility to study extra in regards to the Centafore crew, know-how and its providers in Chicago from Might 30 until June 3 (Sales space #24152).

Centafore supplies know-how and providers for picture administration, processing, and interpretation, empowering examine sponsors with knowledgeable undertaking administration and facilitating superior analyses of imaging knowledge. Its intensive community contains skilled imaging professionals like board-certified radiologists, enabling clients to successfully handle research throughout greater than 50 international locations.

“Centafore represents a big leap ahead in our dedication to enhancing the panorama of medical trial imaging and advancing the event of latest medicines and healthcare options,” stated Nelson Ambrogio, President of Radiology at Bayer. “By leveraging our intensive expertise and experience, we’re devoted to offering our clients with top quality imaging providers that meet their particular wants in medical analysis. By way of Centafore, we intention to boost the reliability of trial outcomes and assist knowledgeable decision-making within the growth of investigational medicines, finally benefiting sufferers and enhancing their high quality of care.”

Centafore’s providers assist a variety of therapeutic areas, together with oncology, cardiovascular, CNS, dermatology, girls’s well being, pediatrics, and digital well being. It goals to assist pharmaceutical, biotech, medical system and digital well being corporations with early analysis via Section IV trials and SaMD growth, and adherence to regulatory and knowledge privateness compliance requirements.

As a part of Bayer’s ongoing efforts to assist international healthcare startups, the Imaging Core Lab Providers of Bayer have been first offered at ECR 2024. Centafore is already collaborating with organizations corresponding to OBIO® and Luxsonic Applied sciences to leverage medical imaging as a crucial software for enhancing decision-making in medical trials and software program as a medical system (SaMD) growth.

About Centafore

Centafore is an Imaging Contract Analysis Group (iCRO) that helps early analysis via section IV trials and Software program as a Medical Gadget (SaMD) growth for pharma, biotech, medical system and digital well being corporations.

For over 25 years, it has been the first, trusted iCRO for Bayer, taking part in a significant position in advancing the corporate’s drug pipeline – and now, prolonged its experience to exterior clients underneath the model identify Centafore, delivering high-quality assist for imaging research and analysis initiatives throughout the business.

About Bayer in Radiology

Constructing on a century of experience, Bayer is dedicated to revolutionary merchandise and high-quality providers in diagnostic imaging to boost affected person care. Its main radiology portfolio options distinction brokers and units for exact administration throughout modalities together with computed tomography (CT), X-ray and magnetic resonance imaging (MRI), and positron emission tomography (PET). Bayer’s complete choices additionally embody informatics options, a curated market with digital and synthetic intelligence (AI) enabled functions. In 2024, Bayer’s radiology merchandise generated €2.1 billion in international gross sales. Dedicated to analysis and innovation, Bayer continues to advance medical imaging with the final word objective to enhance affected person outcomes.

About Bayer

Bayer is a worldwide enterprise with core competencies within the life science fields of well being care and diet. In keeping with its mission, “Well being for all, Starvation for none,” the corporate’s services and products are designed to assist individuals and the planet thrive by supporting efforts to grasp the foremost challenges offered by a rising and growing old international inhabitants. Bayer is dedicated to driving sustainable growth and producing a constructive affect with its companies. On the identical time, the Group goals to extend its incomes energy and create worth via innovation and progress. The Bayer model stands for belief, reliability and high quality all through the world. In fiscal 2024, the Group employed round 93,000 individuals and had gross sales of 46.6 billion euros. R&D bills amounted to six.2 billion euros. For extra data, go to www.bayer.com.

Discover extra data at https://pharma.bayer.com/
Observe us on LinkedIn: Bayer | Prescription drugs
Observe us on Twitter: @BayerPharma

Ahead-Trying Statements

This launch might include forward-looking statements primarily based on present assumptions and forecasts made by Bayer administration. Varied recognized and unknown dangers, uncertainties and different elements may result in materials variations between the precise future outcomes, monetary scenario, growth or efficiency of the corporate and the estimates given right here. These elements embody these mentioned in Bayer’s public experiences which can be found on the Bayer web site at www.bayer.com. The corporate assumes no legal responsibility in any respect to replace these forward-looking statements or to adapt them to future occasions or developments.

Contacts

International media contact:
Simone Leyendecker, cellphone +49 174 9508190
E mail: simone.leyendecker@bayer.com

US media contact:
Jennifer Might, cellphone
E mail: jennifer.might@bayer.com